A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Inferred to overlap with: Df(3L)BSC446.
The breakpoints of Df(3L)BSC830 predicted from the Release 5 genomic coordinates of the progenitor P{XP}RhoGDId10923 and PBac{RB}CG17147e00902 transposable element insertion sites are 3L:19922342 ;20217302 and the cytological breakpoints predicted from these coordinates are 76D5;77A2.